|A Prescription for Gene Therapy|
|The First Cabo Gene Therapy Working Group|
Barbara J. Culliton
November 10, 2000
The report concludes with this summary: "It is a difficult time for gene therapy, but not a fatal one. In many ways, we are experiencing the growing pains of any young field of medicine. Granted, these are magnified for gene therapy, given the uneasy public reaction to the notion of genetic intervention and the intense media scrutiny following recent events. However, just as we have the opportunity to push this young field ahead, we also have the responsibility to adhere to current regulations and to follow tried and true models for developing what are, in essence, new drugs. Far from being a time to retreat, we need to stand up to the public and state clearly our successes and shortcomings, capitalizing on the first and working to change the second."
The full text of "A Prescription for Gene Therapy," from the May issue of Molecular Therapy, is reprinted here.
--Barbara J. Culliton
. . .